OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Organization: The Hebrew University of Jerusalem

2 Projects | 2 Researchers | $540,000 Invested

2019

The Hebrew University of Jerusalem

Yuval Dor, PhD

Non-invasive detection of brain cell death using methylation patterns of circulating DNA: a novel blood test for early detection of Alzheimer’s Disease

  • Funding Amount: $500,000
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Target: Epigenetics
  • Status: Closed

2007

The Hebrew University of Jerusalem

Raz Yirmiya, PhD

The role of brain interleukin-1 in Alzheimer’s disease-associated memory disturbances

  • Funding Amount: $40,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed